Signaling Pathways Tuning Innate Lymphoid Cell Response to Hepatocellular Carcinoma.

Area of Science:

• Immunology
• Oncology
• Hepatology

Background:

• Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally, with rising incidence.
• Chronic infections (hepatitis), cirrhosis, and nonalcoholic steatohepatitis (NASH) are key HCC risk factors.
• While adaptive and myeloid immune cells in HCC are well-studied, innate lymphoid cells (ILCs) roles remain unclear.

Purpose of the Study:

• To review the current understanding of innate lymphoid cells (ILCs) in hepatocellular carcinoma (HCC).
• To highlight the significance of various signaling pathways in modulating ILC function within the HCC microenvironment.

Main Methods:

• Literature review of studies investigating ILCs in HCC.
• Analysis of ILC subsets including Natural Killer (NK) cells, ILC1, ILC2, ILC3, and LTi cells.
• Examination of signaling pathways such as Notch, TGF-β, and Wnt/β-catenin.

Main Results:

• ILCs, predominantly at epithelial surfaces, are rapid responders to environmental cues.
• Tissue-resident ILCs and NK cells play a role in immune responses within the HCC context.
• Specific signaling pathways significantly influence ILC responses in HCC progression.

Conclusions:

• Innate lymphoid cells (ILCs) represent an underappreciated component of the immune landscape in hepatocellular carcinoma (HCC).
• Further research into ILC subsets and their interactions with signaling pathways is essential for developing novel HCC therapies.